News
Verve Therapeutics stock jumped after a report said pharmaceutical giant Eli Lilly is in advanced talks to buy the ...
(Reuters) -Drugmaker Eli Lilly is in advanced talks to acquire gene-editing startup Verve Therapeutics for up to $1.3 billion ...
In April, Verve tweaked the development of the first PCSK9 inhibitor in its programme (VERVE-101) after a trial revealed ...
MacDonald and MacVicar, who were recognized during the recent athletic awards dinner, represented Charlottetown-based Colonel ...
The UK must provide better funding opportunities for research and development across the regions if ambition is going to be ...
Eli Lilly is in talks to buy gene editing partner Verve Therapeutics for up to $1.3 billion, according to a report in ...
Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy for beginners now. On June 11, Eli Lilly announced a ...
LILLY — Lilly Chiropractic topped Imler’s Poultry, 11-2, behind three hits, including two doubles, from Brandon Ickes and ...
LILLY — Lilly Chiropractic topped Imler’s Poultry, 11-2, behind three hits, including two doubles, from Brandon Ickes and four RBIs from Landon Perry in a Greater Altoona City League game on Monday.
The company’s underlying business is thriving, with analysts projecting its market value could hit $1 trillion in the coming ...
Big Pharma executives have not been shy about their desire for deals, but companies have been battling macro headwinds ...
Novo Nordisk (NYSE: NVO) stock had a Monday to forget, as news from a top rival dampened sentiment on the Danish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results